Articles Referencing IMGN
ImmunoGen Narrows Loss - Analyst Blog
4/29/2013, 9:46 am from Zacks.com in Investing, Business, Stocks
ImmunoGen Inc. ( IMGN ) reported third
quarter fiscal 2013 (ending Mar 31) loss of 2 cents per share,
narrower than the Zacks Consensus Estimate of a loss of 14 cents
and the year-ago... Read >>
ImmunoGen to Focus on Pipeline - Analyst Blog
4/15/2013, 7:05 pm from Zacks.com in Investing, Business, Stocks
ImmunoGen Inc. ( IMGN ) recently
provided an update on its pipeline and maintained its outlook for
fiscal year 2013 (ending June 30) at its recently held Analyst
& Investor Day. ... Read >>
Market Wrap for Friday, April 12: Stocks Record Modest Losses; Treasuries Surge and Precious Metals Plunge
4/12/2013, 4:22 pm from Benzinga in Investing, Bonds, Commodities, Futures, International
Although the U.S. stock market shook off worse than expected
retail sales data, volatility hit other markets hard to end the
week. Precious metals were slammed on the retail sales data along... Read >>
Roche Teams Up with Biocare - Analyst Blog
3/1/2013, 5:40 pm from Zacks.com in Investing, Business, Stocks
Roche ( RHHBY ) recently
announced that it has entered into a license agreement with Biocare
Medical, LLC, through one of its wholly-owned subsidiaries, Ventana
Medical Systems, Inc. ... Read >>
FDA Approves Roche's Kadcyla - Analyst Blog
2/25/2013, 5:05 pm from Zacks.com in Investing, Business, Stocks
Roche ( RHHBY ) recently
announced that the US Food and Drug Administration (FDA) has
approved Kadcyla (ado-trastuzumab emtansine or T-DM1) for the
treatment of patients suffering from... Read >>
ImmunoGen Progresses with IMGN901 - Analyst Blog
2/14/2013, 5:44 pm from Zacks.com in Investing, Business, Stocks
ImmunoGen, Inc. ( IMGN ) recently
announced that it has finished enrolling patients for the initial
stage of the two-stage NORTH phase II trial. The trial is being
conducted to assess... Read >>
Wider Loss at ImmunoGen - Analyst Blog
1/28/2013, 9:16 am from Zacks.com in Investing, Business, Stocks
ImmunoGen Inc. ( IMGN ) reported second
quarter fiscal 2013 adjusted loss of 29 cents per share, wider than
both the Zacks Consensus Estimate of a loss of 24 cents and the
year-ago loss of... Read >>
Pre-Market Earnings Report for January 25, 2013 : PG, HON, HAL, KMB, COV, WY, OSK, PB, MOG/A, IMGN, ACO, CMCO
1/24/2013, 4:00 pm from NASDAQ.com News in News Headlines, Earnings
The following companies are expected to report earnings prior to
market open on 01/25/2013. Visit our Earnings
Calendar for a full list of expected earnings releases. Procter & Gamble... Read >>
Opening View: DJIA Looks to Solidify Hold on 11K as Earnings Season Ramps Up
10/11/2010, 7:56 am from Schaeffer's Investment Research in Investing, Options
After closing above the 11,000 level for the first time since
May, the Dow Jones Industrial Average (DJIA) appears to be headed
higher once again this morning. In fact, futures on the DJIA... Read >>
13 Biotechs to Watch for at Hematology Conference
11/30/2009, 5:04 am from SeekingAlpha in Investing, Technology, Stocks
Michael
Becker
submits:
The 51st American Society of Hematology [ASH] Annual Meeting
will take place December 5-8, 2009, at the Ernest N. Morial
Convention Center in New Orleans, LA. This... Read >>